Publication Name	World Journal of Gastroenterology
Manuscript ID	7978
Country	Germany

Received	2013-12-10 18:52
Peer-Review Started	2013-12-11 11:30
To Make the First Decision	2014-01-24 12:26
Return for Revision	2014-01-25 15:14
Revised
Second Decision	2014-06-13 15:56
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2014-06-13 16:17
Articles in Press	2014-06-13 16:25
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2014-09-22 09:41
Publish the Manuscript Online	2014-10-16 15:53

ISSN	1007-9327 (print) and 2219-2840 (online)
Open Access
Copyright
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Topic Highlights
Article Title	Proteomic and metabolic prediction of response to therapy in gastric cancer
Manuscript Source	Invited Manuscript
All Author List	Michaela Aichler, Birgit Luber, Florian Lordick and Axel Walch
Funding Agency and Grant Number	Funding Agency Grant Number Ministry of Education and Research of the Federal Republic of Germany 0315508A Ministry of Education and Research of the Federal Republic of Germany 01IB10004E (to AW) Ministry of Education and Research of the Federal Republic of Germany SYS-Stomach (to BL, FL and AW) Deutsche Forschungsgemeinschaft HO 1258/3-1 Deutsche Forschungsgemeinschaft SFB 824 TP Z02 Deutsche Forschungsgemeinschaft WA 1656/3-1 (to AW)
Corresponding Author	Axel Walch, MD, Professor, Research Unit Analytical Pathology, Institute of Pathology, Helmholtz Zentrum München, German Research Centre for Environmental Health, Ingolstädter Landstraße 1, 85764 Neuherberg, Germany. axel.walch@helmholtz-muenchen.de
Key Words	Gastric cancer; Therapy; Response prediction; positron emission tomography; matrix-assisted laser desorption-ionization
Core Tip	The prognosis of patients diagnosed with gastric cancer is still poor. Cytotoxic treatment and targeted therapies have improved the prognosis of patients. However, patients do not benefit equally from these treatment options. The ability to predict whether patients will respond to specific therapies would be of particular value and would allow for stratifying patients for personalized treatment strategies. In this review, we discuss the status of targeted therapies for gastric cancer, as well as proteomic and metabolic methods for investigating biomarkers for therapy response prediction in gastric cancer.
Publish Date	2014-10-16 15:53
Citation	Aichler M, Luber B, Lordick F, Walch A. Proteomic and metabolic prediction of response to therapy in gastric cancer. World J Gastroenterol 2014; 20(38): 13648-13657
URL	http://www.wjgnet.com/1007-9327/full/v20/i38/13648.htm
DOI	http://dx.doi.org/10.3748/wjg.v20.i38.13648

Full Article (PDF)	WJG-20-13648.pdf
Full Article (Word)	WJG-20-13648.doc
Manuscript File	7978-Review.docx
Answering Reviewers	7978-Answering reviewers.pdf
Copyright License Agreement	7978-Copyright assignment.pdf
Peer-review Report	7978-Peer reivew(s).pdf
Scientific Misconduct Check	7978-CrossCheck.jpg
Scientific Editor Work List	7978-Scientific editor work list.pdf